Kakonein

葛根素

Report date: 2022/08/24 14:20:30
NME

Base Information

Drug NameKakonein
Drug Alias NamePuerarinNPI-031G
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated L-type calcium channel blockersCalcium-activated potassium channel alpha/beta 1 agonists
TargetsCalcium-activated potassium channel alpha/beta 1Voltage-gated L-type calcium channel
Therapy Area/IndicationsAlcoholismObesityMetabolic Diseases +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNatural Pharmacia International
China Registration ClassN/A

Develop Information

Active CompaniesNatural Pharmacia InternationalBeijing Sihuan Kebao Pharmaceutical Co LtdShanghai Rui Jin Hospital
Inactive CompaniesN/A
Active IndicationsAlcoholismObesityMetabolic Diseases +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A